Related Experiment Video
Updated: Oct 2, 2025
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Ferroptosis Involvement in Glioblastoma Treatment
Andrei-Otto Mitre1, Alexandru Ioan Florian2,3, Andrei Buruiana4
1Department of Morphological Sciences, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.
Abstract:
Glioblastoma multiforme (GBM) is one of the deadliest brain tumors. Current standard therapy includes tumor resection surgery followed by radiotherapy and chemotherapy. Due to the tumors invasive nature, recurrences are almost a certainty, giving the patients after diagnosis only a 12-15 months average survival time. Therefore, there is a dire need of finding new therapies that could potentially improve patient outcomes. Ferroptosis is a newly described form of cell death with several implications in cancer, among which GBM. Agents that target different molecules involved in ferroptosis and that stimulate this process have been described as potentially adjuvant anti-cancer treatment options. In GBM, ferroptosis stimulation inhibits tumor growth, improves patient survival, and increases the efficacy of radiation and chemotherapy. This review provides an overview of the current knowledge regarding ferroptosis modulation in GBM.
Insights
Ferroptosis, a novel cell death method, shows promise for treating glioblastoma multiforme (GBM). Stimulating ferroptosis in GBM can inhibit tumor growth and enhance current therapies, offering new hope for patients.
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Glioblastoma multiforme (GBM) is an aggressive brain tumor with a poor prognosis.
- Standard treatments (surgery, radiation, chemotherapy) have limited efficacy due to tumor recurrence.
- Novel therapeutic strategies are urgently needed to improve patient survival rates.
Purpose of the Study:
- To review the current understanding of ferroptosis in the context of glioblastoma multiforme.
- To explore the potential of ferroptosis modulation as an adjuvant therapy for GBM.
- To highlight the implications of ferroptosis stimulation in improving GBM treatment outcomes.
Main Methods:
- Literature review of studies investigating ferroptosis and GBM.
- Analysis of research on agents targeting ferroptosis pathways.
- Synthesis of findings on ferroptosis's role in GBM growth and treatment response.
Main Results:
- Ferroptosis is a distinct form of cell death with significant implications for GBM.
- Targeting ferroptosis pathways can inhibit GBM tumor growth.
- Stimulating ferroptosis enhances the effectiveness of conventional therapies like radiation and chemotherapy.
Conclusions:
- Ferroptosis represents a promising therapeutic target for glioblastoma multiforme.
- Modulating ferroptosis can potentially improve patient survival and treatment efficacy.
- Further research into ferroptosis in GBM could lead to improved clinical outcomes.
